Sustainability: Where do we stand?
By Owen Mumford Pharmaceutical Services
With governments and corporations alike setting targets to be carbon neutral by 2050, it is imperative that the pharmaceutical industry – a heavy polluter historically – looks to reduce its burden on the environment. Michael Earl, director of pharmaceutical services at Owen Mumford, shares findings from the company’s review of the biggest companies in the industry reporting ESG scores, their approach to sustainability, as well as sharing its own progress towards a greener future.